and Human Services (HHS)
INTERNATIONAL COLLABORATIONS IN INFECTIOUS DISEASE RESEARCH (ICIDR) RELEASE DATE: May 17, 2004 NOTICE: NOT-AI-04-030 (Update - see RFA-AI-09-010) National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/) APPLICATION RECEIPT DATE: October 13, 2004 PURPOSE The National Institute of Allergy and Infectious Diseases (NIAID) is amending RFA-AI-04-017, published on April 23, 2004 (http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-017.html), to broaden the scope of clinical research to be supported under the ICIDR program to include (1) tropical diseases caused by NIAID Category A, B and C priority pathogens (listed at http://www.niaid.nih.gov/biodefense/bandc_priority.htm) and (2) additional tropical infections. The RFA as published was limited to research on diseases caused by tropical parasites. This notice provides additional information only and is not a replacement of the original RFA. Scope of Research NIAID maintains a strong commitment to international research related to infectious diseases. Recognizing that many of the priority biodefense pathogens cause diseases of great global health importance, NIAID has restructured parts of the international clinical research program to accelerate efforts in these areas. As part of this restructuring, the ICIDR program is being expanded to include the NIAID Category A, B and C priority pathogens (http://www.niaid.nih.gov/biodefense/bandc_priority.htm) that are endemic in tropical regions. In addition, this Notice expands the ICIDR program to include other infectious diseases that are primarily endemic in, or which disproportionately impact, the health of people living in the tropics, including but not limited to protozoan and helminth infections, mycobacterial disease, and bacterial and viral infections. The focus of the ICIDR program remains on clinical studies, including natural history, epidemiology, and clinical trials (interventional studies). Applications proposing clinical studies in the following areas are particularly encouraged: o NIAID Category A, B and C priority pathogens (http://www2.niaid.nih.gov/Biodefense/bandc_priority.htm), that are endemic in tropical regions, especially enterotoxigenic E. coli, Shigella, hantaviruses, dengue, rift valley fever, Japanese encephalitis virus and West Nile virus o leprosy and Buruli ulcer o hepatitis C outcome differences o hepatitis E in pregnant women o sexually transmitted infections: bacterial vaginosis, Haemophilus ducreyi and trichomoniasis Studies that focus on human immunodeficiency virus (HIV) or the impact of other tropical diseases on HIV infection are not within the scope of this RFA. In addition, studies of sexually transmitted infections (except as noted above), hepatitis (except as noted above), influenza, HSV1&2, RSV, and rotavirus in developing countries are supported by other NIAID activities and are not within the scope of this RFA. Investigators interested in biodefense-related research are also advised to review PA-AI-03-080, BIODEFENSE AND EMERGING INFECTIOUS DISEASE RESEARCH OPPORTUNITIES, which supports basic research, as well as epidemiology and natural history studies of biodefense related agents (Category A, B and C). (See http://grants.nih.gov/grants/guide/pa-files/PA-03-080.html and http://www2.niaid.nih.gov/biodefense/rfalplat.htm). FUNDS AVAILABLE NIAID intends to commit an additional $3M for a total of approximately $10.5M in FY 2005 to fund 10 15 new/and or competitive continuation grants in response to this expanded RFA. SPECIAL REQUIREMENTS SELECT AGENTS: All applicant organizations, domestic and foreign, must comply with Select Agent regulations (http://www.cdc.gov/od/sap/) and NIH Guidelines for Research Involving Recombinant DNA Molecules (http://www4.od.nih.gov/oba/rac/guidelines/guidelines.html). Applicants must document their ability and willingness to comply. INQUIRIES We encourage your inquiries concerning this notice and welcome the opportunity to answer questions from potential applicants: Direct questions about scientific/research issues to: Enteric Bacterial and Viral Pathogens: Lillian van de Verg, Ph.D. Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases Room 4007, MSC-6604 6610 Rockledge Drive Bethesda, MD 20892-6603 Telephone: 301-496-7051 FAX: 301-402-1456 Email: [email protected] Parasitic Diseases: Elizabeth S. Higgs, MD, DTMH, MIA Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases Room 5067, MSC-6604 6610 Rockledge Drive Bethesda, MD 20892-6603 Telephone: 301-402-8372 FAX: 301-402-0659 Email: [email protected] Malla R. Rao, DrPH, M.Eng Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases, DHHS Room 5095, MSC-6604 6610 Rockledge Drive Bethesda, MD 20892 Telephone: 301- 451-3749 FAX: 301-402-0659 Email: [email protected] Respiratory Infections, Leprosy, and Buruli Ulcer: Michael Kurilla, MD, Ph.D. Respiratory Diseases Branch Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, DHHS Room 5030 6610 Rockledge Drive; MSC 6603 Bethesda, MD 20892-6603 Telephone: 301-496-5305 FAX: 301-496-8060 Email: [email protected] Sexually Transmitted Infections: Barbara Savarese, RN, BScN Clinical Research Program Officer STD Branch Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, DHHS 6610 Rockledge Drive Room 5033 Bethesda, MD 20892 Telephone: 301.402.8618 Email: [email protected] Viral Hepatitis: Rajen Koshy, Ph.D. Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases Room 4010, MSC-6604 6610 Rockledge Drive Bethesda, MD 20892-6603 Telephone: 301-496-7051 FAX: 301-402-1456 Email: [email protected] Viral Pathogens: David Morens, MD. Virology Branch Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, DHHS Room 4097 6610 Rockledge Drive; MSC Bethesda, MD 20892-6603 Telephone: 301-496-7453 Email: [email protected] Zoonoses (other than enterics and viruses): Anthony Macaluso, Ph.D. Bacteriology and Mycology Branch Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, DHHS Room 4120 6610 Rockledge Drive; MSC 6604 Bethesda, MD 20892-6604 Telephone: 301-402-0643 FAX: 301-402-2508 Email: [email protected] Direct questions about the overall international program to: Polly R. Sager, Ph.D. Assistant Director for International Research in Infectious Diseases Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, DHHS Room 6005 6610 Rockledge Drive; MSC 7630 Bethesda, MD 20892-7630 Telephone: 301-496-1884 Email: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||